Effects of inhaled magnesium on pulmonary function and walking distance of patients with stable chronic obstructive pulmonary disease (COPD).

Phase 3

Recruiting

• Conditions: Chronic obstructive pulmonary disease; Respiratory - Chronic obstructive pulmonary disease

• Registration Number: ACTRN12608000502336
• Lead Sponsor: José Antônio Baddini Martinez MD, PhD

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-09-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Patients with chronic obstructive pulmonary disase of any severity.

Exclusion Criteria

Active smokers; patients with any cardiac condition, diabetes mellitus or kidney failure.

Study & Design

• Study Type: Interventional
• Study Design: Not specified